Delivery Order SPE2DB22D1017-SPE2DB25FYRBN
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency on May 13, 2025, to supply Methylphenidate ER 18 mg tablets in a quantity of 100 units. The contract is valued at $2,319.50 and carries a firm fixed price with an ultimate completion date of May 14, 2025. This award is classified as a non-set-aside, competitively awarded delivery order and represents a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 18, 2025, for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) with a ceiling value of $1,827.84. This is a firm fixed-price contract with an ultimate completion date of September 19, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive, non-set-aside procurement issued under DLA's...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets (100 count) valued at $2,856.60. This non-competitive, firm fixed-price delivery order is scheduled for completion by August 29, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,176.88 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 27 mg tablets (100-count) on May 6, 2025, with completion scheduled for May 7, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,834.01 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count bottles). This firm fixed-price, competitively awarded contract was issued on August 26, 2025, with an ultimate completion date of August 27, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $2,630.67 to AmerisourceBergen Drug Corp for Methylphenidate ER 27 mg tablets (100-count containers) with an ultimate completion date of September 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,067.06 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count bottles). The contract employs firm fixed-price terms with an ultimate completion date of June 18, 2025, and was awarded on June 17, 2025, without set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $3,511.72 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100 count) with completion scheduled for June 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is performed from the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract on July 14, 2025, valued at approximately $25.5K for the supply of Methylphenidate ER 18mg tablets (100 count). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, under the Defense Logistics Agency's Medical Supply Chain. The contract is set to be completed by August 8, 2025, with performance taking place...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 18 mg tablets (100-count units) with a ceiling value of $2,755.26. This competitively awarded, non-set-aside delivery order carries a firm fixed price structure with an ultimate completion date of September 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYRBNDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $5,234.78 by the Defense Logistics Agency (DLA) for the supply of Methylphenidate ER 27 mg tablets in quantities of 100 units per bottle. This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 18, 2025. The award carries no set-aside designation, indicating the contract was competed among all eligible vendors. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999.99 million and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. Through the DLA Troop Support Medical contract vehicle, the company supplies an extensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. The company's demonstrated capability to fulfill federal medical supply requirements through open competition, combined with its substantial prime IDC with DLA, positions it as a major vendor for military healthcare pharmaceutical needs. This delivery order for methylphenidate, a Schedule II controlled substance commonly prescribed for attention deficit hyperactivity disorder treatment, reflects the company's ongoing role in supporting military medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 9/17/25 |